TBPH Theravance Biopharma, Inc.
Nasdaq · SEC CIK 1583107 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $9.84M 9 sales by 3 insiders
- Filings on record
- 227 since 2021-08-24, latest 2026-09-24 20:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Samaha Eli | 10% | — | $5.91M |
| BROSHY ERAN | Dir | — | $2.47M |
| Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| Sawaf Aziz | SVP, CFO | — | — |
| GRAY SUSANNAH | Dir | — | — |
| O'Connor Donal | Dir | — | — |
| Smaldone Alsup Laurie | Dir | — | — |
| Winningham Rick E | CEO, Dir | — | — |
Transactions 240
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-09 | 2024-08-07 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $7.83 | +3,252 | 1.84M | +0.2% | +$25.5K | |
| I | 2024-08-09 | 2024-08-07 | TBPH | Samaha Eli | 10% | P - Purchase | $7.80 | +999.8K | 9.51M | +12% | +$7.80M |
| 2024-07-12 | 2024-07-10 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.00 | -4,000 | 336.0K | -1% | -$36.0K | |
| 2024-05-22 | 2024-05-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.10 | -9,268 | 340.0K | -3% | -$84.3K | |
| 2024-05-22 | 2024-05-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $9.10 | -9,268 | 351.9K | -3% | -$84.3K | |
| 2024-05-22 | 2024-05-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $9.10 | -16.0K | 1.84M | -0.9% | -$145.6K | |
| 2024-05-22 | 2024-05-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $9.10 | -8,635 | 330.0K | -3% | -$78.6K | |
| 2024-05-22 | 2024-05-20 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | F - Tax | $9.10 | -5,201 | 165.8K | -3% | -$47.3K | |
| 2024-05-17 | 2024-05-15 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $9.85 | +2,068 | 1.85M | +0.1% | +$20.4K | |
| D | 2024-05-10 | 2024-05-08 | TBPH | BROSHY ERAN | Dir | A - Grant | $0.00 | +10.5K | 80.6K | +15% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | Grant Jeremy T | Dir | A - Grant | $0.00 | +10.5K | 22.3K | +90% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +10.5K | 80.6K | +15% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | O'Connor Donal | Dir | A - Grant | $0.00 | +10.5K | 63.6K | +20% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +10.5K | 31.5K | +50% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | PAKIANATHAN DEEPIKA | Dir | A - Grant | $0.00 | +10.5K | 47.4K | +29% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | Smaldone Alsup Laurie | Dir | A - Grant | $0.00 | +10.5K | 64.3K | +20% | $0 |
| MI | 2024-05-03 | 2024-05-01 | TBPH | Samaha Eli | 10% | P - Purchase | $8.75 | +1.50M | 8.51M | +21% | +$13.12M |
| 2024-04-04 | 2024-04-02 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | A - Grant | $0.00 | +100.0K | 360.7K | +38% | $0 | |
| 2024-04-04 | 2024-04-02 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +300.0K | 1.85M | +19% | $0 | |
| 2024-04-04 | 2024-04-02 | TBPH | Sawaf Aziz | SVP, CFO | A - Grant | $0.00 | +100.0K | 338.6K | +42% | $0 | |
| 2024-04-04 | 2024-04-02 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +37.5K | 349.2K | +12% | $0 | |
| 2024-04-04 | 2024-04-02 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | A - Grant | $0.00 | +37.5K | 171.0K | +28% | $0 | |
| 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $8.64 | +2,704 | 1.56M | +0.2% | +$23.4K | |
| I | 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | +3,900 | 3,900 | New | $0 |
| M | 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -10.9K | 1.55M | -0.7% | $0 |
| 2024-02-22 | 2024-02-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $8.92 | -18.2K | 313.0K | -6% | -$162.5K | |
| 2024-02-22 | 2024-02-22 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $8.71 | -1,254 | 311.7K | -0.4% | -$10.9K | |
| 2024-02-22 | 2024-02-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $8.92 | -17.0K | 238.6K | -7% | -$152.0K | |
| 2024-02-22 | 2024-02-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $8.92 | -19.3K | 314.9K | -6% | -$172.1K | |
| 2024-02-22 | 2024-02-20 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | F - Tax | $8.92 | -11.8K | 133.5K | -8% | -$105.1K | |
| 2024-02-22 | 2024-02-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $8.92 | -17.6K | 260.7K | -6% | -$156.9K | |
| 2024-02-22 | 2024-02-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $8.92 | -37.2K | 1.56M | -2% | -$331.8K | |
| DM | 2023-12-26 | 2023-12-21 | TBPH | Grant Jeremy T | Dir | A - Grant | $0.00 | +11.8K | 8,826 | New | $0 |
| 2023-11-22 | 2023-11-21 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.29 | -1,378 | 331.2K | -0.4% | -$14.2K | |
| 2023-11-22 | 2023-11-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.37 | -7,982 | 332.6K | -2% | -$82.8K | |
| 2023-11-22 | 2023-11-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $10.37 | -15.8K | 1.60M | -1.0% | -$163.9K | |
| 2023-11-22 | 2023-11-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.37 | -12.6K | 334.2K | -4% | -$131.0K | |
| 2023-11-22 | 2023-11-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $10.37 | -6,187 | 255.7K | -2% | -$64.2K | |
| 2023-11-22 | 2023-11-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $10.37 | -7,363 | 278.3K | -3% | -$76.4K | |
| 2023-11-16 | 2023-11-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.22 | -2,482 | 346.8K | -0.7% | -$25.4K | |
| 2023-11-01 | 2023-10-30 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | A - Grant | $0.00 | +15.0K | 349.3K | +4% | $0 | |
| 2023-10-18 | 2023-10-16 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.03 | -2,482 | 334.3K | -0.7% | -$22.4K | |
| 2023-09-18 | 2023-09-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.89 | -2,482 | 336.8K | -0.7% | -$24.5K | |
| 2023-08-24 | 2023-08-22 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.47 | -1,807 | 340.6K | -0.5% | -$17.1K | |
| 2023-08-22 | 2023-08-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.70 | -10.5K | 342.4K | -3% | -$101.5K | |
| 2023-08-22 | 2023-08-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $9.70 | -7,114 | 261.9K | -3% | -$69.0K | |
| 2023-08-22 | 2023-08-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $9.70 | -15.8K | 1.61M | -1.0% | -$153.3K | |
| 2023-08-22 | 2023-08-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $9.70 | -8,912 | 285.3K | -3% | -$86.4K | |
| 2023-08-22 | 2023-08-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $9.70 | -10.5K | 339.3K | -3% | -$101.5K | |
| 2023-08-15 | 2023-08-11 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.99 | -2,322 | 349.7K | -0.7% | -$23.2K | |
| 2023-07-18 | 2023-07-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.84 | -2,322 | 352.1K | -0.7% | -$22.8K | |
| 2023-06-16 | 2023-06-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.69 | -2,322 | 354.4K | -0.7% | -$24.8K | |
| 2023-06-12 | 2023-06-08 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $11.13 | -1,790 | 352.8K | -0.5% | -$19.9K | |
| 2023-05-23 | 2023-05-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $11.21 | -11.5K | 294.2K | -4% | -$128.6K | |
| 2023-05-23 | 2023-05-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $11.21 | -8,744 | 269.0K | -3% | -$98.0K | |
| 2023-05-23 | 2023-05-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $11.21 | -10.5K | 356.7K | -3% | -$117.3K | |
| 2023-05-23 | 2023-05-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $11.21 | -15.8K | 1.63M | -1.0% | -$177.2K | |
| 2023-05-23 | 2023-05-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $11.21 | -5,567 | 354.6K | -2% | -$62.4K | |
| 2023-05-17 | 2023-05-15 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.26 | -2,322 | 367.2K | -0.6% | -$26.1K | |
| D | 2023-05-04 | 2023-05-02 | TBPH | PAKIANATHAN DEEPIKA | Dir | A - Grant | $0.00 | +9,132 | 36.9K | +33% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +9,132 | 21.0K | +77% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | BROSHY ERAN | Dir | A - Grant | $0.00 | +9,132 | 70.0K | +15% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | O'Connor Donal | Dir | A - Grant | $0.00 | +9,132 | 53.0K | +21% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +9,132 | 70.0K | +15% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | MALKIEL BURTON G | Dir | A - Grant | $0.00 | +9,132 | 100.6K | +10% | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | Smaldone Alsup Laurie | Dir | A - Grant | $0.00 | +9,132 | 53.8K | +20% | $0 |
| 2023-04-18 | 2023-04-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.88 | -2,323 | 369.5K | -0.6% | -$27.6K | |
| 2023-03-16 | 2023-03-14 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.32 | -2,323 | 371.8K | -0.6% | -$24.0K | |
| 2023-03-13 | 2023-03-09 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.20 | -4,000 | 360.2K | -1% | -$40.8K | |
| 2023-03-08 | 2023-03-06 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.05 | -2,323 | 374.1K | -0.6% | -$23.3K | |
| 2023-03-03 | 2023-03-01 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $0.00 | +330.0K | 1.64M | +25% | $0 | |
| 2023-03-03 | 2023-03-01 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | A - Grant | $0.00 | +75.0K | 376.5K | +25% | $0 | |
| 2023-03-03 | 2023-03-01 | TBPH | Sawaf Aziz | SVP, CFO | A - Grant | $0.00 | +80.0K | 277.7K | +40% | $0 | |
| 2023-03-03 | 2023-03-01 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | A - Grant | $0.00 | +75.0K | 305.0K | +33% | $0 | |
| 2023-03-03 | 2023-03-01 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +75.0K | 364.2K | +26% | $0 | |
| DM | 2023-02-28 | 2023-02-26 | TBPH | GRAY SUSANNAH | Dir | A - Grant | $0.00 | +11.8K | 10.1K | New | $0 |
| 2023-02-22 | 2023-02-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $10.44 | -37.4K | 1.31M | -3% | -$390.7K | |
| 2023-02-22 | 2023-02-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.44 | -12.1K | 301.5K | -4% | -$125.9K | |
| 2023-02-22 | 2023-02-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.44 | -7,119 | 289.2K | -2% | -$74.3K | |
| 2023-02-22 | 2023-02-20 | TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | F - Tax | $10.44 | -10.2K | 230.0K | -4% | -$106.5K | |
| 2023-02-22 | 2023-02-20 | TBPH | Sawaf Aziz | SVP, CFO | F - Tax | $10.44 | -6,783 | 197.7K | -3% | -$70.8K | |
| 2022-12-16 | 2022-12-14 | TBPH | Winningham Rick E | CEO, Dir | S - Sale | $11.19 | -50.0K | 1.35M | -4% | -$559.5K | |
| 2022-12-16 | 2022-12-13 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | — | -9,000 | 1.40M | -0.6% | — | |
| 2022-12-05 | 2022-12-01 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.73 | -2,084 | 313.5K | -0.7% | -$22.4K | |
| 2022-11-23 | 2022-11-22 | TBPH | O'Connor Donal | Dir | D - Sale to Iss | $10.50 | -10.0K | 43.9K | -19% | -$105.0K | |
| 2022-11-22 | 2022-11-18 | TBPH | Hindman Andrew A. | SVP, CFO | S - Sale | $11.02 | -65.0K | 409.8K | -14% | -$716.3K | |
| 2022-11-22 | 2022-11-20 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $10.85 | -25.1K | 384.7K | -6% | -$271.9K | |
| 2022-11-22 | 2022-11-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.85 | -23.3K | 296.3K | -7% | -$252.5K | |
| 2022-11-22 | 2022-11-20 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $10.85 | -15.8K | 1.41M | -1% | -$171.5K | |
| 2022-11-22 | 2022-11-20 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.85 | -27.4K | 315.6K | -8% | -$296.7K | |
| 2022-11-17 | 2022-11-16 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $11.20 | -2,800 | 343.0K | -0.8% | -$31.4K | |
| DI | 2022-09-20 | 2022-09-16 | TBPH | GSK PLC | Former 10% Owner | J - Other | $9.75 | -9.64M | 0 | -100% | -$94.04M |
| 2022-08-23 | 2022-08-19 | TBPH | Hindman Andrew A. | SVP, CFO | F - Tax | $9.34 | -25.7K | 473.5K | -5% | -$239.8K | |
| 2022-08-23 | 2022-08-19 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $9.34 | -19.0K | 345.8K | -5% | -$177.4K | |
| 2022-08-23 | 2022-08-19 | TBPH | Winningham Rick E | CEO, Dir | F - Tax | $9.34 | -15.8K | 1.42M | -1% | -$147.6K | |
| 2022-08-23 | 2022-08-19 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.34 | -10.4K | 319.6K | -3% | -$97.3K | |
| 2022-08-18 | 2022-08-16 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | S - Sale | $9.71 | -4,906 | 364.7K | -1% | -$47.6K | |
| 2022-08-11 | 2022-08-09 | TBPH | GRAHAM RICHARD A | SVP, DEVELOPMENT | S - Sale | $8.79 | -15.1K | 369.7K | -4% | -$132.6K | |
| 2022-07-27 | 2022-07-25 | TBPH | Hindman Andrew A. | SVP, CFO | A - Grant | $0.00 | +20.0K | 499.2K | +4% | $0 | |
| 2022-05-24 | 2022-05-23 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $8.93 | -1,081 | 330.0K | -0.3% | -$9,653 |
Purchase Sale Sale after option exercise All abbreviations